Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics.

doi:10.7150/ijms.38080

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics.

International journal of medical sciences - 1 Jan 2019

Lin Chia-Yen, Wang Shian-Shiang, Yang Cheng-Kuang, Li Jian-Ri, Chen Chuan-Shu, Hung Sheng-Chun, Chiu Kun-Yuan, Cheng Chen-Li, Ou Yen-Chuan, Yang Shun-Fa

Abstract excerpt

Down-regulation of Growth arrest-specific 5 (GAS5) is correlated with enhanced cell proliferation and poorer prognosis of prostate cancer. We aimed to investigate the effect of variant rs145204276 of GAS5 on the prostate cancer susceptibility and clinicopathologic characteristics. In this study, 579 prostate cancer patients who underwent robot-assisted radical prostatectomy and 579 healthy controls were included....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Proliferation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Lymphatic Metastasis

Share to Prognosis

Share to Promoter Regions, Genetic

Share to Prostatectomy

Share to Prostatic Neoplasms

Share to RNA, Long Noncoding

Source

Open in PubMed Open full text

Identifiers

PMID: 31673232
DOI: 10.7150/ijms.38080
PMCID: PMC6818208

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics.PMID 31673232Read ↗

Association of long-chain non-coding RNA GAS5 gene polymorphisms with prostate cancer risk and prognosis in Chinese Han population.Semantic proximity Read ↗

Association between long non-coding RNA (lncRNA) GAS5 polymorphism rs145204276 and cancer risk.Semantic proximity Read ↗

Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma.Semantic proximity Read ↗

LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer.Semantic proximity Read ↗

The Variant rs145204276 of GAS5 is Associated with the Development and Prognosis of Gastric Cancer.Semantic proximity Read ↗

Growth arrest-specific 5 (GAS5) insertion/deletion polymorphism and cancer susceptibility in Asian populations: A meta-analysis.Semantic proximity Read ↗

LncRNA growth arrest-special 5 polymorphisms and predisposition to cancer: A meta-analysis.Semantic proximity Read ↗

Association between polymorphism in the promoter region of lncRNA GAS5 and the risk of colorectal cancerSemantic proximity Read ↗

Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications.Semantic proximity Read ↗

LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A.Semantic proximity Read ↗

Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.Semantic proximity Read ↗

Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.